Biofrontera (BFRI)

• Market cap: $8.92M
• 1 day: 0.72%
• 5 days: -7.25%
• 1 month: -5.32%
• 3 months: -14.89%
• 6 months: 25.16%
• Year to date: -29.72%
• 1 year: -24.9%
• 5 years: -99.13%
• 10 years: -99.13%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Employees: 93